Neurology News

You’ve made the decision to sell your practice, got your house in order and hired advisers. Now you need to start making decisions regarding the terms of the sale.

The Alzheimer’s Disease-Health Index is a reliable tool for individuals to self-report changes in symptoms or response to therapy, according to research presented at the Alzheimer’s Association International Conference.

Individuals with essential tremor may have an increased risk of decline in attentional abilities when having less habitual sleep efficiency, according to a poster presentation at the Alzheimer’s Association International Conference.

Seven researchers were honored at the Alzheimer’s Association International Conference for their expertise, contributions and achievements in advancing the field of Alzheimer’s and dementia science, according to an association release.

The long-term stroke risk for Black women rose by an estimated 66% if they had history with hypertensive disorders of pregnancy, possibly contributing to their overall higher incidence of stroke compared with other racial groups, data show.

A systematic literature review determined that various classes of blood pressure-lowering medication reduced frequency of migraine days per month compared with placebo, according to a study published in Cephalalgia.

Long COVID symptoms widely ranged based on the severity of the acute illness phase, demonstrating the need for individualized and multidisciplinary care, according to researchers.

BOSTON — With a multitude of products spanning neuroscience and psychiatry, executives at AbbVie say they are committed to learning the full clinical value of all of the company’s products for the benefit of patients.

Genentech announced positive results from its phase 3 OCARINA II clinical trial evaluating Ocrevus as a twice-a-year, 10-minute subcutaneous injection for those with relapsing forms of MS or primary progressive MS.

The FDA has approved a software update for a deep brain stimulation system intended to assist clinicians in the treatment of those with Parkinson’s disease or essential tremor.